BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18784648)

  • 1. Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice.
    Revsin Y; Rekers NV; Louwe MC; Saravia FE; De Nicola AF; de Kloet ER; Oitzl MS
    Neuropsychopharmacology; 2009 Feb; 34(3):747-58. PubMed ID: 18784648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RU486 (mifepristone) ameliorates cognitive dysfunction and reverses the down-regulation of astrocytic N-myc downstream-regulated gene 2 in streptozotocin-induced type-1 diabetic rats.
    Zuo ZF; Wang W; Niu L; Kou ZZ; Zhu C; Wang W; Zhao XH; Luo DS; Zhang T; Zhang FX; Liu XZ; Wu SX; Li YQ
    Neuroscience; 2011 Sep; 190():156-65. PubMed ID: 21712075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin treatment partially prevents cognitive and hippocampal alterations as well as glucocorticoid dysregulation in early-onset insulin-deficient diabetic rats.
    Marissal-Arvy N; Campas MN; Semont A; Ducroix-Crepy C; Beauvieux MC; Brossaud J; Corcuff JB; Helbling JC; Vancassel S; Bouzier-Sore AK; Touyarot K; Ferreira G; Barat P; Moisan MP
    Psychoneuroendocrinology; 2018 Jul; 93():72-81. PubMed ID: 29702445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal hypersensitivity precedes chronic hypercorticism in streptozotocin-induced diabetes mice.
    Revsin Y; van Wijk D; Saravia FE; Oitzl MS; De Nicola AF; de Kloet ER
    Endocrinology; 2008 Jul; 149(7):3531-9. PubMed ID: 18420743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats.
    Oitzl MS; Fluttert M; Sutanto W; de Kloet ER
    Eur J Neurosci; 1998 Dec; 10(12):3759-66. PubMed ID: 9875354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with the glucocorticoid receptor antagonist RU486 inhibits diabetes-induced enhancement of experimental periodontitis.
    Breivik T; Gundersen Y; Gjermo P; Opstad PK
    J Periodontal Res; 2014 Feb; 49(1):36-44. PubMed ID: 23586673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FX5, a non-steroidal glucocorticoid receptor antagonist, ameliorates diabetic cognitive impairment in mice.
    Zhu DY; Lu J; Xu R; Yang JZ; Meng XR; Ou-Yang XN; Yan QY; Nie RF; Zhao T; Chen YD; Lu Y; Zhang YN; Li WJ; Shen X
    Acta Pharmacol Sin; 2022 Oct; 43(10):2495-2510. PubMed ID: 35260821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glucocorticoid receptors ameliorates hypobaric hypoxia induced memory impairment in rat.
    Baitharu I; Deep SN; Jain V; Prasad D; Ilavazhagan G
    Behav Brain Res; 2013 Mar; 240():76-86. PubMed ID: 23159706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: a putative post-traumatic stress disorder model.
    Kohda K; Harada K; Kato K; Hoshino A; Motohashi J; Yamaji T; Morinobu S; Matsuoka N; Kato N
    Neuroscience; 2007 Aug; 148(1):22-33. PubMed ID: 17644267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid receptor activation induces decrease of hippocampal astrocyte number in rats.
    Lou YX; Li J; Wang ZZ; Xia CY; Chen NH
    Psychopharmacology (Berl); 2018 Sep; 235(9):2529-2540. PubMed ID: 30069586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of corticotropin-releasing hormone receptor 1 attenuates early-life stress-induced synaptic abnormalities in the neonatal hippocampus.
    Liao XM; Yang XD; Jia J; Li JT; Xie XM; Su YA; Schmidt MV; Si TM; Wang XD
    Hippocampus; 2014 May; 24(5):528-40. PubMed ID: 24493406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes.
    Alvarez EO; Beauquis J; Revsin Y; Banzan AM; Roig P; De Nicola AF; Saravia F
    Behav Brain Res; 2009 Mar; 198(1):224-30. PubMed ID: 19041902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid- and long-term stress-induced aberrant synaptic plasticity are mediated by activation of the glucocorticoid receptor.
    Park HJ; Lee S; Jung JW; Kim BC; Ryu JH; Kim DH
    Arch Pharm Res; 2015 Jun; 38(6):1204-12. PubMed ID: 25564339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypercorticism during streptozotocin diabetes and mifepristone administration: the role of cyclic adenosine monophosphate].
    Selyatitskaya VG; Afonnikova ED; Pal Chikova NA; Kuz Minova OI
    Biomed Khim; 2019 Jun; 65(4):311-315. PubMed ID: 31436172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice.
    Meyer M; Gonzalez Deniselle MC; Hunt H; de Kloet ER; De Nicola AF
    J Steroid Biochem Mol Biol; 2014 Sep; 143():40-8. PubMed ID: 24565565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid receptor antagonism prevents microglia-mediated neuronal remodeling and behavioral despair following chronic unpredictable stress.
    Horchar MJ; Wohleb ES
    Brain Behav Immun; 2019 Oct; 81():329-340. PubMed ID: 31255679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of glucocorticoid receptors increases 5-HT2A receptor levels.
    Trajkovska V; Kirkegaard L; Krey G; Marcussen AB; Thomsen MS; Chourbaji S; Brandwein C; Ridder S; Halldin C; Gass P; Knudsen GM; Aznar S
    Exp Neurol; 2009 Jul; 218(1):83-91. PubMed ID: 19379741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids decrease astrocyte numbers by reducing glucocorticoid receptor expression in vitro and in vivo.
    Unemura K; Kume T; Kondo M; Maeda Y; Izumi Y; Akaike A
    J Pharmacol Sci; 2012; 119(1):30-9. PubMed ID: 22641130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal glucocorticoid excess due to pituitary glucocorticoid receptor deficiency: differential short- and long-term consequences.
    Schmidt MV; Sterlemann V; Wagner K; Niederleitner B; Ganea K; Liebl C; Deussing JM; Berger S; Schütz G; Holsboer F; Müller MB
    Endocrinology; 2009 Jun; 150(6):2709-16. PubMed ID: 19213843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.